Pharmaceuticals · Market research

Oral GLP-1 Drugs reports

Coverage across 33 countries and regions. Researched figures and forecasts come with the full report.

Get the full Oral GLP-1 Drugs market evidence

The purchased report supplies researched market size, forecast, growth, segments, competition and sources.

Buy the full report Request free sample
Oral GLP-1 Drugs reports by place
PlaceCurrent sizeForecastGrowthActive trialsReport
WorldIn full reportIn full reportIn full report3View report
AfricaIn full reportIn full reportIn full report0View report
APACIn full reportIn full reportIn full report2View report
AustraliaIn full reportIn full reportIn full report1View report
BrazilIn full reportIn full reportIn full report0View report
CanadaIn full reportIn full reportIn full report0View report
ChinaIn full reportIn full reportIn full report1View report
EcuadorIn full reportIn full reportIn full report0View report
EgyptIn full reportIn full reportIn full report0View report
EuropeIn full reportIn full reportIn full report1View report
FranceIn full reportIn full reportIn full report0View report
GermanyIn full reportIn full reportIn full report0View report
Hong KongIn full reportIn full reportIn full report0View report
IndiaIn full reportIn full reportIn full report0View report
ItalyIn full reportIn full reportIn full report0View report
JapanIn full reportIn full reportIn full report0View report
KenyaIn full reportIn full reportIn full report0View report
Latin AmericaIn full reportIn full reportIn full report0View report
MalaysiaIn full reportIn full reportIn full report0View report
MexicoIn full reportIn full reportIn full report0View report
Middle EastIn full reportIn full reportIn full report0View report
New ZealandIn full reportIn full reportIn full report0View report
North AmericaIn full reportIn full reportIn full report0View report
PhilippinesIn full reportIn full reportIn full report0View report
RussiaIn full reportIn full reportIn full report0View report
Saudi ArabiaIn full reportIn full reportIn full report0View report
SingaporeIn full reportIn full reportIn full report0View report
South AfricaIn full reportIn full reportIn full report0View report
SpainIn full reportIn full reportIn full report0View report
ThailandIn full reportIn full reportIn full report0View report
UAEIn full reportIn full reportIn full report0View report
UKIn full reportIn full reportIn full report1View report
USIn full reportIn full reportIn full report0View report

Public clinical research

3 active trials found worldwide on ClinicalTrials.gov.

See the public search

Latest public research

  1. Efficacy and safety of oral orforglipron in Japanese participants with obesity disease (ATTAIN-J): a double-blind, randomised, placebo-controlled, parallel-group, phase 3 trial.The lancet. Diabetes & endocrinology, 2026
  2. Progress in Anti-Obesity Drug Development: A Pharmacodynamics Perspective.Pharmaceutics, 2026
  3. Real-world Challenges and Predictors of Success in Glucagon-like Peptide-1 Receptor Agonist Therapy.The Journal of the Association of Physicians of India, 2026
  4. Antidiabetic medications in the pipeline.Hormones (Athens, Greece), 2026
  5. Adherence and Persistence to Injectable versus Oral GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus: A Comparative Systematic Review and Analysis.Diabetes, metabolic syndrome and obesity : targets and therapy, 2026

Public trial and paper counts come from ClinicalTrials.gov and PubMed. Acuitas market figures are not published on this page.